Pyruvate identified as a promising therapeutic agent for ulcerative colitis by targeting cytosolic phospholipase A2
2025-07-01
(Press-News.org)
A groundbreaking study published in Genes & Diseases has revealed that exogenous pyruvate significantly alleviates the symptoms of ulcerative colitis (UC) by targeting cytosolic phospholipase A2 (cPLA2). This discovery opens new avenues for the treatment of UC, which remains a chronic inflammatory bowel disease with limited therapeutic options. The study shows that pyruvate can suppress the TNFα/NFκB signaling pathway, which is pivotal in driving inflammation, thereby offering a novel approach to mitigating UC symptoms.
Ulcerative colitis is characterized by chronic intestinal inflammation, leading to symptoms such as abdominal pain, diarrhea, rectal bleeding, and weight loss. Current treatments, including aminosalicylic acids, glucocorticoids, and immunosuppressants, often present significant side effects and limited efficacy. Moreover, biological therapies targeting TNFα, though effective, lack oral formulations, making them less convenient for patients. The discovery of pyruvate as an orally administered therapeutic alternative holds promise for improving patient outcomes.
The research team conducted extensive in vitro and in vivo experiments to investigate the anti-inflammatory potential of pyruvate. Initial screening of various cellular metabolites identified pyruvate as the most potent inhibitor of TNFα/NFκB signaling. In mouse models of dextran sodium sulfate (DSS)-induced colitis, pyruvate administration significantly reduced colonic inflammation, maintained tight junction integrity, and improved overall clinical disease activity indices. Histopathological analysis revealed that pyruvate preserved colonic structure and reduced immune cell infiltration, suggesting its ability to stabilize the intestinal mucosal barrier.
Further molecular investigations identified cPLA2 as a previously unrecognized target of pyruvate. Through drug affinity responsive target stability (DARTS) assays and cellular thermal shift assays (CETSA), the researchers demonstrated that pyruvate binds directly to cPLA2, stabilizing it and preventing its degradation. This interaction is crucial as cPLA2 mediates the production of pro-inflammatory lipid mediators, including arachidonic acid, which activate the NFκB pathway and exacerbate colitis. In cPLA2-deficient mice, pyruvate lost its therapeutic efficacy, confirming that its anti-inflammatory effects are mediated through this enzyme.
Importantly, the study showed that pyruvate effectively reduced the levels of key pro-inflammatory cytokines such as IL-1β and IL-6 in both the serum and colonic tissues of treated mice. Additionally, pyruvate administration was shown to normalize the expression of tight junction proteins such as claudin-2, ZO-1, and occludin, which are critical in maintaining intestinal barrier function. The therapeutic effects of pyruvate were comparable to those of 5-aminosalicylic acid (5-ASA), a standard UC treatment, but with the added benefit of being an oral small molecule.
These findings not only position pyruvate as a potential novel oral therapy for ulcerative colitis but also highlight the therapeutic relevance of targeting cPLA2 in inflammatory bowel diseases. By inhibiting the TNFα/NFκB pathway, pyruvate may also prove beneficial in other TNFα-associated inflammatory conditions. Future clinical trials are warranted to validate these promising preclinical results and establish pyruvate’s role in human UC management.
# # # # #
Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the molecular bases of human diseases. Emphasis is placed on hypothesis-driven, mechanistic studies relevant to pathogenesis and/or experimental therapeutics of human diseases. The journal has worldwide authorship, and a broad scope in basic and translational biomedical research of molecular biology, molecular genetics, and cell biology, including but not limited to cell proliferation and apoptosis, signal transduction, stem cell biology, developmental biology, gene regulation and epigenetics, cancer biology, immunity and infection, neuroscience, disease-specific animal models, gene and cell-based therapies, and regenerative medicine.
Scopus CiteScore: 8.4
Impact Factor: 9.4
# # # # # #
More information: https://www.keaipublishing.com/en/journals/genes-and-diseases/
Editorial Board: https://www.keaipublishing.com/en/journals/genes-and-diseases/editorial-board/
All issues and articles in press are available online in ScienceDirect (https://www.sciencedirect.com/journal/genes-and-diseases ).
Submissions to Genes & Disease may be made using Editorial Manager (https://www.editorialmanager.com/gendis/default.aspx ).
Print ISSN: 2352-4820
eISSN: 2352-3042
CN: 50-1221/R
Contact Us: editor@genesndiseases.com
X (formerly Twitter): @GenesNDiseases (https://x.com/GenesNDiseases )
# # # # # #
Reference
Sadaf Hasan, Nabil Ghani, Xiangli Zhao, Julia Good, Chuan-ju Liu, Exogenous pyruvate is therapeutic against colitis by targeting cytosolic phospholipase A2, Genes & Diseases, 2025, 101571, https://doi.org/10.1016/j.gendis.2025.101571
Funding Information:
US National Institutes of Health (NIH) research grant R01AR062207
US National Institutes of Health (NIH) research grant R01AR061484
US National Institutes of Health (NIH) research grant R01AR076900
US National Institutes of Health (NIH) research grant R01AR078035
US National Institutes of Health (NIH) research grant R01NS070328
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-07-01
A recent study published in Genes & Diseases explores the clinical implications of loss-of-function mutations in IKBKG/NEMO, a key regulator in the NF-κB signaling pathway. These mutations are linked to a range of rare and often severe genetic disorders, including Incontinentia Pigmenti (IP), Anhidrotic Ectodermal Dysplasia with Immunodeficiency (EDA-ID), Immunodeficiency (ID), and NEMO Deleted Exon 5 Autoinflammatory Syndrome (NDAS). The research aims to provide a comprehensive review of the diverse clinical manifestations ...
2025-07-01
Images
A new blue fluorescent molecule set new top emission efficiencies in both solid and liquid states, according to a University of Michigan-led study that could pave the way for applications in technology and medicine.
Able to absorb light and emit it at lower energy levels, fluorescent molecules called fluorophores glow in OLED displays and help doctors and scientists figure out what's happening in cells and tissues. They need to be solid in displays and many sensing applications, but liquids are typically preferred for biological uses. ...
2025-07-01
For a decade, scientists have believed that plants sensed temperature mainly through specialized proteins, and mainly at night when the air is cool. New research suggests that during the day, another signal takes over. Sugar, produced in sunlight, helps plants detect heat and decide when to grow.
The study, led by Meng Chen, a University of California, Riverside professor of cell biology, shows that plants rely on multiple heat-sensing systems, and that sugar plays a central and previously unrecognized role in daytime temperature response. The findings, published in Nature Communications, reshape a long-standing view of how plants ...
2025-07-01
The lucrative pay for American CEOs often makes headlines. In 1965, CEO compensation was 22 times higher than the pay of an average worker. In recent years, CEOs have been paid 344 times more than the people who work for them.
The personality of a CEO is one factor driving the increase in executive compensation, according to a new study from a team of researchers that includes Sam M. Walton College of Business strategic management professor Jason Ridge.
Leaders with a Machiavellian personality, someone who is self-interested, unemotional and manipulative, earn more than $1.5 million a year in additional pay. While ...
2025-07-01
While the current generation of artificial intelligence chatbots still flub basic facts, the systems answer with such confidence that they’re often more persuasive than humans.
Adults, even those such as lawyers with deep domain knowledge, still regularly fall for this. But spotting errors in text is especially difficult for children, since they often don’t have the contextual knowledge to sniff out falsehoods.
University of Washington researchers developed the game AI Puzzlers to show kids an area where AI systems still typically and blatantly ...
2025-07-01
By Greg Watry, UC Davis
Archaeologists have long thought that monumental architecture — large, human-built structures that emphasize visibility — were products of societies with power structures, including social hierarchy, inequality and controlled labor forces. But this notion is being questioned as researchers uncover evidence that hunter-gatherer groups also built such structures.
In new research published June 24 in the journal Antiquity, University of California researchers report evidence of monumental structures built by hunter-gatherer groups at Kaillachuro, a collection of burial mounds located in the Titicaca Basin of the ...
2025-07-01
The strength of certain neural connections can predict how well someone can learn math, and mild electrically stimulating these networks can boost learning, according to a study published on July 1st in the open-access journal PLOS Biology by Roi Cohen Kadosh from University of Surrey, United Kingdom, and colleagues.
When it comes to cognitive skills like reading and math, early advantages tend to compound over time. Mathematical abilities, however, seem to plateau from childhood to adulthood, raising the possibility that innate brain characteristics ...
2025-07-01
Putting the brakes on an enzyme might rescue neurons that are dying due to a type of Parkinson’s disease that’s caused by a single genetic mutation, according to a new Stanford Medicine-led study conducted in mice.
The genetic mutation causes an enzyme called leucine-rich repeat kinase 2, or LRRK2, to be overactive. Too much LRRK2 enzyme activity changes the structure of brain cells in a way that disrupts crucial communication between neurons that make the neurotransmitter dopamine and cells in the striatum, ...
2025-07-01
Safe, painless, and non-invasive brain stimulation could help people who are at risk of falling behind in maths, according to a new study led by the University of Surrey.
The study, published in PLoS Biology, found that applying safe electrical currents to the dorsolateral prefrontal cortex (dlPFC) – a region involved in learning and memory, focus, and problem-solving – helped people aged 18 to 30 solve maths problems more efficiently.
Seventy-two healthy adults took part in a five-day maths training programme – 24 received a form of brain stimulation known as transcranial random noise stimulation (tRNS) to the dlPFC, ...
2025-07-01
Under embargo until July 1, 2025 at 11am PST / 2pm EST / 7pm GMT)
Neurotechnology reverses biological disadvantage in maths learning
Safe, painless, and non-invasive brain stimulation could help people who are at risk of falling behind in maths, according to a new study led by the University of Surrey.
The study, published in PLoS Biology, found that applying safe electrical currents to the dorsolateral prefrontal cortex (dlPFC) – a region involved in learning and memory, focus, and problem-solving – helped people aged 18 to ...
LAST 30 PRESS RELEASES:
[Press-News.org] Pyruvate identified as a promising therapeutic agent for ulcerative colitis by targeting cytosolic phospholipase A2
